Noema Pharma

Noema Pharma is a clinical-stage biotech company developing transformative therapeutics for neuroscience-based conditions with high unmet needs. They have four programs in Phase 2 clinical trials targeting conditions such as seizures, pain, Tourette syndrome, and menopause symptoms, with data readouts expected in 2025. Their focus is on delivering first-in-disease treatments.

Buy Funded Startups lists

Funding Round: Series B+

Funding Amount: $147M

Date: 11-Dec-2024

Investors: EQT Life Sciences, Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus, UPMC Enterprises

Markets: Biotech, Neuroscience, Pharmaceuticals

HQ: Basel, Basel-Stadt, Switzerland

Founded: 2019

Website: https://noemapharma.com/

LinkedIn: https://www.linkedin.com/company/noema-pharma-ag

Twitter:

Instagram: